Contact
searchSearch
HMP Global
Login
News
Coffee May Reduce Risk for Disease Progression, Death in Patients With CRC
11/12/2020
Findings from a cohort study of patients with advanced or metastatic CRC showed that increased coffee consumption was linked to a lower risk for disease progression and death.
Findings from a cohort study of patients with advanced or metastatic CRC showed that increased coffee consumption was linked to a lower risk for disease progression and death.
Findings from a cohort study of...
11/12/2020
Oncology
Veena Shankaran, MD, MS, Discusses Financial Hardships in Patients With Metastatic CRC
Podcasts
Veena Shankaran, MD, MS, Discusses Financial Hardships in Patients With Metastatic CRC
09/20/2020
Dr Shankaran, discusses a study assessing financial toxicity in patients with metastatic CRC, and the upcoming expansion of the trial.
Dr Shankaran, discusses a study assessing financial toxicity in patients with metastatic CRC, and the upcoming expansion of the trial.
Dr Shankaran, discusses a study...
09/20/2020
Oncology
Conference Insider
Ablative Therapy for Early HCC Reduces Mortality, Hospitalization vs Surgery
08/15/2020
At the Great Debates & Updates in GI Cancer, Constantinos Sofocleous, MD, PhD, participated in a lively debate on the optimal treatment of early HCC, and spoke in favor of ablation.
At the Great Debates & Updates in GI Cancer, Constantinos Sofocleous, MD, PhD, participated in a lively debate on the optimal treatment of early HCC, and spoke in favor of ablation.
At the Great Debates & Updates...
08/15/2020
Oncology
News
Ursodeoxycholic Acid Prevents Gallstone Formation After Gastric Cancer Surgery
08/07/2020
Patients who received ursodeoxycholic acid following gastrectomy for gastric cancer developed significantly fewer gallstones than those given placebo, according to results of the PEGASUS-D trial.
Patients who received ursodeoxycholic acid following gastrectomy for gastric cancer developed significantly fewer gallstones than those given placebo, according to results of the PEGASUS-D trial.
Patients who received...
08/07/2020
Oncology
Conference Insider
Experts Develop Nomogram That Predicts Survival in Patients With Unresectable Pancreatic Cancer
07/01/2020
Findings from a study presented at the ESMO World Congress on GI Cancer posit that a nomogram can conveniently predict survival in patients with unresectable pancreatic cancer.
Findings from a study presented at the ESMO World Congress on GI Cancer posit that a nomogram can conveniently predict survival in patients with unresectable pancreatic cancer.
Findings from a study presented...
07/01/2020
Oncology
Researchers Identify Predictors of RILD in Patients With HCC
Interview
Researchers Identify Predictors of RILD in Patients With HCC
01/06/2020
Cheng-En Hsieh, MD, discusses a study identifying predictors of radiation-induced liver disease (RILD) in patients with HCC treated with proton beam therapy.
Cheng-En Hsieh, MD, discusses a study identifying predictors of radiation-induced liver disease (RILD) in patients with HCC treated with proton beam therapy.
Cheng-En Hsieh, MD, discusses a...
01/06/2020
Oncology
Interview
Novel Findings Could Help Predict Pancreatic NET Recurrence
07/24/2019
Ramesh A. Shivdasani, MD, PhD, discusses a study that unveiled molecular information predicting the risk for recurrence of non-functional pNETs.
Ramesh A. Shivdasani, MD, PhD, discusses a study that unveiled molecular information predicting the risk for recurrence of non-functional pNETs.
Ramesh A. Shivdasani, MD, PhD,...
07/24/2019
Oncology

Recent News

News
Coffee May Reduce Risk for Disease Progression, Death in Patients With CRC
11/12/2020
Findings from a cohort study of patients with advanced or metastatic CRC showed that increased coffee consumption was linked to a lower risk for disease progression and death.
Findings from a cohort study of patients with advanced or metastatic CRC showed that increased coffee consumption was linked to a lower risk for disease progression and death.
Findings from a cohort study of...
11/12/2020
Oncology
News
Ursodeoxycholic Acid Prevents Gallstone Formation After Gastric Cancer Surgery
08/07/2020
Patients who received ursodeoxycholic acid following gastrectomy for gastric cancer developed significantly fewer gallstones than those given placebo, according to results of the PEGASUS-D trial.
Patients who received ursodeoxycholic acid following gastrectomy for gastric cancer developed significantly fewer gallstones than those given placebo, according to results of the PEGASUS-D trial.
Patients who received...
08/07/2020
Oncology

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use